InvestorsHub Logo

Biobillionair

10/25/19 10:31 AM

#221062 RE: KCSVEN #221058

It’s not ripe to share unless the FDA takes actions regarding Vascepa AMARIN briefing materials...

Here:
https://www.fda.gov/advisory-committees/november-14-2019-meeting-endocrinologic-and-metabolic-drugs-advisory-committee-meeting-announcement

I do not know what the FDA will do, I do not know what AMARIN will do....

I do know what AMARIN must do to prevent further shareholder law suits post Ad Com.

BB